N-(3,4-Dichlorophenyl)-2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetamide

Catalog No. :
ACFLUO353
CAS No. :
329078-57-1
Molecular Formula :
C14H13Cl2N3OS
Molecular Weight :
342.25

IUPAC Name:N-(3,4-dichlorophenyl)-2-((4,6-dimethylpyrimidin-2-yl)thio)acetamide

N-(3,4-Dichlorophenyl)-2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3,4-Dichlorophenyl)-2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetamide
IUPAC NameN-(3,4-dichlorophenyl)-2-((4,6-dimethylpyrimidin-2-yl)thio)acetamide
MDL No.MFCD00169105
Molecular FormulaC14H13Cl2N3OS
Molecular Weight342.25
SMILESO=C(NC1=CC=C(Cl)C(Cl)=C1)CSC2=NC(C)=CC(C)=N2
InChI KeyXNWQKWRHXIPLEY-UHFFFAOYSA-N
SynonymN-(3,4-dichlorophenyl)-2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetamide;Acetamide, N-(3,4-dichlorophenyl)-2-[(4,6-dimethyl-2-pyrimidinyl)thio]-
CAS No.329078-57-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFLUO353 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFLUO353 route product structure diagram
    ACFLUO353329078-57-1
Inquiry

2. ACFLUO353 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDHKV710 route compound structure diagram
    ACDHKV71022325-27-5 In Stock
  2. Plus
  3. ACDBIH579 route compound structure diagram
    ACDBIH57920149-84-2 In Stock
  4. Then
  5. ACFLUO353 route product structure diagram
    ACFLUO353329078-57-1
Inquiry

Comments (0)